Identifying Outcomes in Clinical Trials of Pouchitis for the Development of a Core Outcome Set.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
07 2019
Historique:
received: 05 09 2018
revised: 19 09 2018
accepted: 21 09 2018
pubmed: 1 10 2018
medline: 22 10 2020
entrez: 1 10 2018
Statut: ppublish

Résumé

Treatment targets in both randomized controlled trials (RCTs) and daily practice have evolved for patients with ulcerative colitis (UC), motivated by changing regulatory requirements and efforts to alter the disease's natural history. Substantial heterogeneity in outcome definitions has been identified in UC RCTs.

Identifiants

pubmed: 30268563
pii: S1542-3565(18)31074-7
doi: 10.1016/j.cgh.2018.09.042
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1637-1640

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Christopher Ma (C)

Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada; Robarts Clinical Trials, Inc, London, Ontario, Canada.

Jonathan Athayde (J)

Department of Medicine, Western University, London, Ontario, Canada.

Sarah C Davies (SC)

Department of Medicine, Western University, London, Ontario, Canada.

Claire E Parker (CE)

Robarts Clinical Trials, Inc, London, Ontario, Canada.

Tran M Nguyen (TM)

Robarts Clinical Trials, Inc, London, Ontario, Canada.

Reena Khanna (R)

Robarts Clinical Trials, Inc, London, Ontario, Canada; Department of Medicine, Western University, London, Ontario, Canada.

Brian G Feagan (BG)

Robarts Clinical Trials, Inc, London, Ontario, Canada; Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.

Vipul Jairath (V)

Robarts Clinical Trials, Inc, London, Ontario, Canada; Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address: vjairath@uwo.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH